Company / Free Cash Flow
Illumina, Inc. Free Cash Flow History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow
$931.0M
FY2025
5-year range
$283.0M / $931.0M
FY2021-FY2025
Trend
+31.3%
vs FY2024
Sector context
#31 of 151
Health Care
What the data says
Illumina, Inc.'s free cash flow of $931M is higher than 79% of companies in the Health Care sector (FY2025). Free Cash Flow has fluctuated over the past 10 years, ranging from $283M in FY2023 to $931M in FY2025.
Based on SEC 10-K filings.
$931M in FY2025 with a 5-year CAGR of +0.9%. Top quartile in the Health Care sector.
Improved from $283M to $931M over the past 2 years.
Health Care sector context is included.
Free Cash Flow over time
Growth rates
- 3-Year CAGR
- +1.5%
- 5-Year CAGR
- +0.9%
- 10-Year CAGR
- -
Sector benchmark
Top 21% in Health CareTop 21% of 151This company $931.0M Sector average $779.8M
▼
+19.4% above sector average
Key checks
Key Insights
- 5-year CAGR of +0.9%, indicating consistent growth.
- In FY2025, free cash flow increased 31.3% year-over-year.
- Ranks #31 out of 151 companies in the Health Care sector.
- Lowest free cash flow in the period was in FY2023.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
- Strong return on equity: 29.5%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $931.0M | +31.3% |
| FY2024 | $709.0M | +150.5% |
| FY2023 | $283.0M | -68.2% |
| FY2022 | $891.0M | +164.4% |
| FY2021 | $337.0M | -62.2% |
| FY2020 | $891.0M | +57.7% |
| FY2019 | $565.0M | +8.9% |
| FY2018 | $519.0M | -19.3% |
| FY2017 | $643.0M | +23.9% |
| FY2016 | $519.0M | -19.3% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026